{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T03:02:21Z","timestamp":1781924541436,"version":"3.54.5"},"reference-count":57,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.jinf.2019.02.003","type":"journal-article","created":{"date-parts":[[2019,2,10]],"date-time":"2019-02-10T14:26:02Z","timestamp":1549808762000},"page":"382-392","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"title":["Novel genetically-modified chimpanzee adenovirus and MVA-vectored respiratory syncytial virus vaccine safely boosts humoral and cellular immunity in healthy older adults"],"prefix":"10.1016","volume":"78","author":[{"given":"Christopher A.","family":"Green","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles J.","family":"Sande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Scarselli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Capone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Vitelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo","family":"Nicosia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Silva-Reyes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amber J.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine M.","family":"de Lara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn S.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn","family":"Haworth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire L.","family":"Hutchings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamsin","family":"Cargill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Angus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Klenerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Pollard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jinf.2019.02.003_bib0001","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1093\/infdis\/172.2.389","article-title":"Respiratory syncytial virus and influenza a infections in the hospitalized elderly","volume":"172","author":"Falsey","year":"1995","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.jinf.2019.02.003_bib0002","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1532-5415.1995.tb06238.x","article-title":"Acute respiratory tract infection in daycare centers for older persons","volume":"43","author":"Falsey","year":"1995","journal-title":"J Am Geriatr Soc"},{"issue":"6","key":"10.1016\/j.jinf.2019.02.003_bib0003","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S1473-3099(13)70046-X","article-title":"AS03-adjuvanted versus non-adjuvanted inactivated trivalent influenza vaccine against seasonal influenza in elderly people: a phase 3 randomised trial","volume":"13","author":"McElhaney","year":"2013","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"10.1016\/j.jinf.2019.02.003_bib0004","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s40266-015-0258-9","article-title":"Respiratory syncytial virus infection in older adults: an under-recognized problem","volume":"32","author":"Branche","year":"2015","journal-title":"Drugs Aging"},{"issue":"8","key":"10.1016\/j.jinf.2019.02.003_bib0005","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1093\/cid\/cit471","article-title":"High morbidity and mortality in adults hospitalized for respiratory syncytial virus infections","volume":"57","author":"Lee","year":"2013","journal-title":"Clin Infect Dis An official publication of the infectious diseases society of America"},{"issue":"6","key":"10.1016\/j.jinf.2019.02.003_bib0006","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1046\/j.1365-2389.2003.51254.x","article-title":"Influenza- and respiratory syncytial virus-associated morbidity and mortality in the nursing home population","volume":"51","author":"Ellis","year":"2003","journal-title":"J Am Geriatr Soc"},{"issue":"2","key":"10.1016\/j.jinf.2019.02.003_bib0007","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1001\/jama.289.2.179","article-title":"Mortality associated with influenza and respiratory syncytial virus in the United States","volume":"289","author":"Thompson","year":"2003","journal-title":"JAMA J Am Med Assoc"},{"issue":"17","key":"10.1016\/j.jinf.2019.02.003_bib0008","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1056\/NEJMoa043951","article-title":"Respiratory syncytial virus infection in elderly and high-risk adults","volume":"352","author":"Falsey","year":"2005","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.jinf.2019.02.003_bib0009","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1093\/infdis\/jis415","article-title":"Mortality attributable to 9 common infections: significant effect of influenza A, respiratory syncytial virus, influenza B, norovirus, and parainfluenza in elderly persons","volume":"206","author":"van Asten","year":"2012","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.jinf.2019.02.003_bib0010","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1093\/infdis\/jis309","article-title":"Rates of hospitalizations for respiratory syncytial virus, human metapneumovirus, and influenza virus in older adults","volume":"206","author":"Widmer","year":"2012","journal-title":"J Infect Dis"},{"issue":"10","key":"10.1016\/j.jinf.2019.02.003_bib0011","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1093\/cid\/cis211","article-title":"Hospitalizations associated with influenza and respiratory syncytial virus in the United States, 1993-2008","volume":"54","author":"Zhou","year":"2012","journal-title":"Clin Infect Dis An official publication of the Infectious Diseases Society of America"},{"issue":"7","key":"10.1016\/j.jinf.2019.02.003_bib0012","doi-asserted-by":"crossref","first-page":"577","DOI":"10.2165\/00002512-200522070-00004","article-title":"Respiratory syncytial virus infection in elderly adults","volume":"22","author":"Falsey","year":"2005","journal-title":"Drugs Aging"},{"key":"10.1016\/j.jinf.2019.02.003_bib0013","doi-asserted-by":"crossref","first-page":"15018","DOI":"10.1038\/mtm.2015.18","article-title":"Mucosal delivery of a vectored RSV vaccine is safe and elicits protective immunity in rodents and nonhuman primates","volume":"2","author":"Pierantoni","year":"2015","journal-title":"Mol Ther Methods Clin Dev"},{"issue":"300","key":"10.1016\/j.jinf.2019.02.003_bib0014","first-page":"300ra127","article-title":"Efficacy of a virus-vectored vaccine against human and bovine respiratory syncytial virus infections","volume":"7","author":"Taylor","year":"2015","journal-title":"Sci Translat Med"},{"issue":"3","key":"10.1016\/j.jinf.2019.02.003_bib0015","doi-asserted-by":"crossref","first-page":"e55435","DOI":"10.1371\/journal.pone.0055435","article-title":"Vaccination to conserved influenza antigens in mice using a novel Simian adenovirus vector, PanAd3, derived from the bonobo Pan paniscus","volume":"8","author":"Vitelli","year":"2013","journal-title":"PloS One"},{"issue":"300","key":"10.1016\/j.jinf.2019.02.003_bib0016","first-page":"300ra126","article-title":"Chimpanzee adenovirus- and MVA-vectored respiratory syncytial virus vaccine is safe and immunogenic in adults","volume":"7","author":"Green","year":"2015","journal-title":"Sci Translat Med"},{"issue":"10","key":"10.1016\/j.jinf.2019.02.003_bib0017","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-008748","volume":"5","author":"Green","year":"2015","journal-title":"BMJ Open"},{"issue":"3","key":"10.1016\/j.jinf.2019.02.003_bib0018","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1089\/104303404322886147","article-title":"Quantitative adenovirus neutralization assays based on the secreted alkaline phosphatase reporter gene: application in epidemiologic studies and in the design of adenovector vaccines","volume":"15","author":"Aste-Amezaga","year":"2004","journal-title":"Hum Gene Ther"},{"issue":"10","key":"10.1016\/j.jinf.2019.02.003_bib0019","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1007\/s00262-010-0875-4","article-title":"Response definition criteria for ELISPOT assays revisited","volume":"59","author":"Moodie","year":"2010","journal-title":"Cancer Immun Immunother CII"},{"issue":"21","key":"10.1016\/j.jinf.2019.02.003_bib0020","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1056\/NEJM199311183292102","article-title":"Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. The Respiratory Syncytial Virus Immune Globulin Study Group","volume":"329","author":"Groothuis","year":"1993","journal-title":"N Engl J Med"},{"issue":"3 Pt 1","key":"10.1016\/j.jinf.2019.02.003_bib0021","first-page":"531","article-title":"Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. The IMpact-RSV Study Group","volume":"102","year":"1998","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.jinf.2019.02.003_bib0022","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/2191-1991-3-18","article-title":"A cost-effectiveness analysis of respiratory syncytial virus (RSV) prophylaxis in infants in the United Kingdom","volume":"3","author":"Bentley","year":"2013","journal-title":"Health Econ Rev"},{"issue":"4","key":"10.1016\/j.jinf.2019.02.003_bib0023","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1067\/S0022-3476(03)00454-2","article-title":"Palivizumab prophylaxis reduces hospitalization due to respiratory syncytial virus in young children with hemodynamically significant congenital heart disease","volume":"143","author":"Feltes","year":"2003","journal-title":"J Pediatr"},{"issue":"7","key":"10.1016\/j.jinf.2019.02.003_bib0024","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1093\/cid\/cir955","article-title":"Role of neutralizing antibodies in adults with community-acquired pneumonia by respiratory syncytial virus","volume":"54","author":"Luchsinger","year":"2012","journal-title":"Clin Infect Dis An official publication of the Infectious Diseases Society of America"},{"issue":"2","key":"10.1016\/j.jinf.2019.02.003_bib0025","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1086\/421524","article-title":"Humoral and mucosal immunity in protection from natural respiratory syncytial virus infection in adults","volume":"190","author":"Walsh","year":"2004","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.jinf.2019.02.003_bib0026","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1086\/517376","article-title":"Relationship of serum antibody to risk of respiratory syncytial virus infection in elderly adults","volume":"177","author":"Falsey","year":"1998","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.jinf.2019.02.003_bib0027","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1128\/CVI.00580-12","article-title":"Adults 65 years old and older have reduced numbers of functional memory T cells to respiratory syncytial virus fusion protein","volume":"20","author":"Cherukuri","year":"2013","journal-title":"Clin Vaccine Immunol CVI"},{"issue":"2","key":"10.1016\/j.jinf.2019.02.003_bib0028","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/(SICI)1096-9071(199910)59:2<221::AID-JMV16>3.0.CO;2-H","article-title":"Comparison of respiratory syncytial virus humoral immunity and response to infection in young and elderly adults","volume":"59","author":"Falsey","year":"1999","journal-title":"J Med Virol"},{"issue":"6","key":"10.1016\/j.jinf.2019.02.003_bib0029","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1164\/rccm.200510-1681OC","article-title":"Detection of respiratory syncytial virus in adults with chronic obstructive pulmonary disease","volume":"173","author":"Falsey","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jinf.2019.02.003_bib0030","doi-asserted-by":"crossref","first-page":"10224","DOI":"10.1038\/ncomms10224","article-title":"RSV-specific airway resident memory CD8+ T cells and differential disease severity after experimental human infection","volume":"6","author":"Jozwik","year":"2015","journal-title":"Nat Commun"},{"issue":"8","key":"10.1016\/j.jinf.2019.02.003_bib0031","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1093\/infdis\/jit832","article-title":"Respiratory syncytial virus in hematopoietic cell transplant recipients: factors determining progression to lower respiratory tract disease","volume":"209","author":"Kim","year":"2014","journal-title":"J Infect Dis"},{"issue":"11","key":"10.1016\/j.jinf.2019.02.003_bib0032","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1086\/657158","article-title":"Circulating antibody-secreting cells during acute respiratory syncytial virus infection in adults","volume":"202","author":"Lee","year":"2010","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jinf.2019.02.003_bib0033","doi-asserted-by":"crossref","DOI":"10.1164\/rccm.201412-2256OC","article-title":"Impaired antibody-mediated protection and defective IgA B cell memory in experimental infection of adults with respiratory syncytial virus","author":"Habibi","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"issue":"41","key":"10.1016\/j.jinf.2019.02.003_bib0034","doi-asserted-by":"crossref","first-page":"6183","DOI":"10.1016\/j.vaccine.2018.08.056","article-title":"Humoral and cellular immunity to RSV in infants, children and adults","volume":"36","author":"Green","year":"2018","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.jinf.2019.02.003_bib0035","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1086\/380907","article-title":"Risk factors for severe respiratory syncytial virus infection in elderly persons","volume":"189","author":"Walsh","year":"2004","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jinf.2019.02.003_bib0036","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1742-4933-7-14","article-title":"Age related changes in T cell mediated immune response and effector memory to Respiratory Syncytial Virus (RSV) in healthy subjects","volume":"7","author":"Cusi","year":"2010","journal-title":"Immun Ageing I & A"},{"issue":"10","key":"10.1016\/j.jinf.2019.02.003_bib0037","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1086\/429695","article-title":"Respiratory syncytial virus-specific CD8+ memory T cell responses in elderly persons","volume":"191","author":"de Bree","year":"2005","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.jinf.2019.02.003_bib0038","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1128\/IAI.00740-09","article-title":"Prime-boost immunization with adenoviral and modified vaccinia virus Ankara vectors enhances the durability and polyfunctionality of protective malaria CD8+ T-cell responses","volume":"78","author":"Reyes-Sandoval","year":"2010","journal-title":"Inf Immun"},{"issue":"261","key":"10.1016\/j.jinf.2019.02.003_bib0039","first-page":"261ra153","article-title":"A human vaccine strategy based on chimpanzee adenoviral and MVA vectors that primes, boosts, and sustains functional HCV-specific T cell memory","volume":"6","author":"Swadling","year":"2014","journal-title":"Sci Translat Med"},{"issue":"11","key":"10.1016\/j.jinf.2019.02.003_bib0040","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1038\/nm1128","article-title":"Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans","volume":"10","author":"McShane","year":"2004","journal-title":"Nat Med"},{"issue":"10","key":"10.1016\/j.jinf.2019.02.003_bib0041","doi-asserted-by":"crossref","first-page":"e48322","DOI":"10.1371\/journal.pone.0048322","article-title":"A T cell-inducing influenza vaccine for the elderly: safety and immunogenicity of MVA-NP+M1 in adults aged over 50 years","volume":"7","author":"Antrobus","year":"2012","journal-title":"PloS One"},{"issue":"15","key":"10.1016\/j.jinf.2019.02.003_bib0042","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1001\/jama.2016.4218","article-title":"Safety and Immunogenicity of Novel Adenovirus Type 26- and Modified Vaccinia Ankara-Vectored Ebola Vaccines: a randomized clinical trial","volume":"315","author":"Milligan","year":"2016","journal-title":"JAMA The J Am Med Assoc"},{"issue":"9\u201310","key":"10.1016\/j.jinf.2019.02.003_bib0043","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/S0264-410X(01)00471-6","article-title":"Cold-adapted live influenza vaccine versus inactivated vaccine: systemic vaccine reactions, local and systemic antibody response, and vaccine efficacy. A meta-analysis","volume":"20","author":"Beyer","year":"2002","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.jinf.2019.02.003_bib0044","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1128\/JVI.01957-06","article-title":"Comparison of the influenza virus-specific effector and memory B-cell responses to immunization of children and adults with live attenuated or inactivated influenza virus vaccines","volume":"81","author":"Sasaki","year":"2007","journal-title":"J Virol"},{"issue":"10","key":"10.1016\/j.jinf.2019.02.003_bib0045","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1084\/jem.20051365","article-title":"Selective accumulation of differentiated CD8+ T cells specific for respiratory viruses in the human lung","volume":"202","author":"de Bree","year":"2005","journal-title":"J Exper Med"},{"issue":"9653","key":"10.1016\/j.jinf.2019.02.003_bib0046","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/S0140-6736(08)61591-3","article-title":"Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial","volume":"372","author":"Buchbinder","year":"2008","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.jinf.2019.02.003_bib0047","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1093\/infdis\/jis342","article-title":"Extended follow-up confirms early vaccine-enhanced risk of HIV acquisition and demonstrates waning effect over time among participants in a randomized trial of recombinant adenovirus HIV vaccine (Step Study)","volume":"206","author":"Duerr","year":"2012","journal-title":"J Infect Dis"},{"issue":"50","key":"10.1016\/j.jinf.2019.02.003_bib0048","doi-asserted-by":"crossref","first-page":"E3503","DOI":"10.1073\/pnas.1208972109","article-title":"Merck Ad5\/HIV induces broad innate immune activation that predicts CD8(+) T-cell responses but is attenuated by preexisting Ad5 immunity","volume":"109","author":"Zak","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"issue":"205","key":"10.1016\/j.jinf.2019.02.003_bib0049","first-page":"205ra134","article-title":"A human type 5 adenovirus-based tuberculosis vaccine induces robust T cell responses in humans despite preexisting anti-adenovirus immunity","volume":"5","author":"Smaill","year":"2013","journal-title":"Sci Translat Med"},{"issue":"11","key":"10.1016\/j.jinf.2019.02.003_bib0050","doi-asserted-by":"crossref","first-page":"7179","DOI":"10.4049\/jimmunol.174.11.7179","article-title":"Neutralizing antibodies to adenovirus serotype 5 vaccine vectors are directed primarily against the Adenovirus Hexon Protein","volume":"174","author":"Sumida","year":"2005","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.jinf.2019.02.003_bib0051","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1128\/JVI.06165-11","article-title":"Adenovirus serotype 5-specific neutralizing antibodies target multiple hexon hypervariable regions","volume":"86","author":"Bradley","year":"2012","journal-title":"J Virol"},{"issue":"4","key":"10.1016\/j.jinf.2019.02.003_bib0052","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1586\/erv.13.15","article-title":"Development of chimpanzee adenoviruses as vaccine vectors: challenges and successes emerging from clinical trials","volume":"12","author":"Capone","year":"2013","journal-title":"Expert Rev Vaccines"},{"issue":"22","key":"10.1016\/j.jinf.2019.02.003_bib0053","doi-asserted-by":"crossref","first-page":"4709","DOI":"10.1016\/j.vaccine.2006.03.029","article-title":"Immunogenicity of the candidate malaria vaccines FP9 and modified vaccinia virus Ankara encoding the pre-erythrocytic antigen ME-TRAP in 1-6 year old children in a malaria endemic area","volume":"24","author":"Bejon","year":"2006","journal-title":"Vaccine"},{"issue":"6136","key":"10.1016\/j.jinf.2019.02.003_bib0054","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1126\/science.1234914","article-title":"Structure of RSV fusion glycoprotein trimer bound to a prefusion-specific neutralizing antibody","volume":"340","author":"McLellan","year":"2013","journal-title":"Science"},{"issue":"6158","key":"10.1016\/j.jinf.2019.02.003_bib0055","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1126\/science.1243283","article-title":"Structure-based design of a fusion glycoprotein vaccine for respiratory syncytial virus","volume":"342","author":"McLellan","year":"2013","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.jinf.2019.02.003_bib0056","doi-asserted-by":"crossref","first-page":"3089","DOI":"10.1073\/pnas.1115941109","article-title":"Neutralizing antibodies against the preactive form of respiratory syncytial virus fusion protein offer unique possibilities for clinical intervention","volume":"109","author":"Magro","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7491","key":"10.1016\/j.jinf.2019.02.003_bib0057","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/nature12966","article-title":"Proof of principle for epitope-focused vaccine design","volume":"507","author":"Correia","year":"2014","journal-title":"Nature"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445319300386?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445319300386?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T21:26:39Z","timestamp":1759008399000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445319300386"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":57,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["S0163445319300386"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2019.02.003","relation":{},"ISSN":["0163-4453"],"issn-type":[{"value":"0163-4453","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel genetically-modified chimpanzee adenovirus and MVA-vectored respiratory syncytial virus vaccine safely boosts humoral and cellular immunity in healthy older adults","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2019.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The British Infection Association. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}